Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$135.05 - $182.59 $1,350 - $1,825
-10 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$145.58 - $192.14 $6.27 Million - $8.27 Million
-43,050 Reduced 99.98%
10 $1,000
Q2 2021

Aug 13, 2021

BUY
$134.22 - $202.37 $5.78 Million - $8.71 Million
43,050 Added 430500.0%
43,060 $8.43 Million
Q1 2021

May 14, 2021

BUY
$140.25 - $196.86 $1,402 - $1,968
10 New
10 $2,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.58B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Berkshire Capital Holdings Inc Portfolio

Follow Berkshire Capital Holdings Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Berkshire Capital Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Berkshire Capital Holdings Inc with notifications on news.